Read Article

Supporting international business matching, LSMIP propritizes "Speed" and "Accuracy" in out service.
Please be noted that contents are in English/Japanese, translated on a request basis from authors/members.



Selection of API CDMO - Part 3/3

The primary objective of this article is to introduce the reader to the process of identifying, selecting, negotiating, implementing and managing API (Active Pharmaceutical Ingredient) CMOs or CDMOs.
  • Target market
    Japan, USA, Other countries
  • Business category
    Pharmaceutical, Biopharmaceutical, Others
  • Business function
    Clinical development > CRO selection, Engineering, production, GMP > , Business consulting >
  • Keyword
  • Author
    "Nelson M Lugo" of "Nelson M Lugo Consulting"
  • Availability


Selection of API CDMOs – Part 3
Nelson M. Lugo, Owner and Principle Consultant of Nelson M Lugo Consultants
19 August 2019

  This is Part 2 of a Series of 3 segments outlining the pivotal phases in securing the right CDMO API partner with due diligence for long term success.  Following the article "Selection of API CDMO - Part 2/3", the steps and stages that will be covered in this Part include;  marked up in bold below.

(Table of content)
Part 1
    - The Teams
    - Stage 1 - Planning and Organization
Part 2
    - Stage 2 - Select
    - Stage 3 - Negotiate
Part 3
    - Stage 4 - Implement
    - Stage 5 - Manage
    - Expected Deliverables
    - Timeline


Series articles

Comments (Require approval)

What information are you looking for in articles?
Let us help you to find out the articles for your business requirements!
Like many other companies, we use cookies and other technologies, some of which are essential to make our website work. By clicking Accept or continuing to use our site, you agree to use these cookies and other technologies. To learn more, check out our privacy policy.